Heartflow, Inc.
HTFL
33 insider filings · Latest: Jun 24, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | Jun 26 10:08 PM | John C.M. FarquharDirector, Chief Executive Officer | Sale | 38,900 | $35.00 | $1.4M | 457,935(D) | View → |
| Jun 24, 2026 | Jun 24 2:38 PM | Farquhar John C.M. | Proposed Sale | 38,900 | $35.00 | $1.4M | — | View → |
| Jun 10, 2026 | Jun 12 10:55 PM | John C.M. FarquharDirector, Chief Executive Officer | Sale | 22,562 | $28.50 | $643.0K | 496,835(D) | View → |
| Jun 10, 2026 | Jun 10 2:47 PM | Farquhar John C.M. | Proposed Sale | 22,562 | $28.50 | $643.0K | — | View → |
| May 18, 2026 | May 20 9:55 PM | Campbell RogersChief Medical Officer | Sale | 9,219 | $28.34 | $261.3K | 78,731(D) | View → |
| May 18, 2026 | May 18 3:48 PM | Rogers Campbell | Proposed Sale | 9,219 | $28.34 | $261.3K | — | View → |
| May 11, 2026 | May 13 10:23 PM | John C.M. FarquharDirector, Chief Executive Officer | Sale | 22,562 | $29.12 | $657.0K | 519,397(D) | View → |
| May 11, 2026 | May 11 2:20 PM | Farquhar John C.M. | Proposed Sale | 22,562 | $29.12 | $657.0K | — | View → |
| Apr 30, 2026 | May 1 12:46 AM | Bain Capital Life Sciences Investors, LLC10% Owner | Sale | 948,757 | $29.23 | $27.7M | 8,448,158(I) | View → |
| Apr 29, 2026 | May 1 12:46 AM | Bain Capital Life Sciences Investors, LLC10% Owner | Sale | 797,133 | $29.37 | $23.4M | 9,396,915(I) | View → |
| Apr 28, 2026 | May 1 12:46 AM | Bain Capital Life Sciences Investors, LLC10% Owner | Sale | 254,110 | $30.51 | $7.8M | 10,194,048(I) | View → |
| Apr 10, 2026 | Apr 14 9:53 PM | John C.M. FarquharDirector, Chief Executive Officer | Sale | 22,562 | $26.72 | $602.9K | 549,163(D) | View → |
| Apr 10, 2026 | Apr 10 3:03 PM | Farquhar John C.M. | Proposed Sale | 22,562 | $26.72 | $602.9K | — | View → |
| Apr 1, 2026 | Apr 3 10:15 PM | Campbell RogersChief Medical Officer | Sale | 64,533 | $24.64 | $1.6M | 81,002(D) | View → |
| Apr 1, 2026 | Apr 1 8:23 PM | Rogers Campbell | Proposed Sale | 64,533 | $24.64 | $1.6M | — | View → |
| Mar 19, 2026 | Mar 23 10:33 PM | Campbell RogersChief Medical Officer | Sale | 64,533 | $25.69 | $1.7M | 78,518(D) | View → |
| Mar 18, 2026 | Mar 20 10:24 PM | John C.M. FarquharDirector, Chief Executive Officer | Sale | 9,725 | $25.00 | $243.1K | 571,725(D) | View → |
| Mar 19, 2026 | Mar 19 8:23 PM | Rogers Campbell | Proposed Sale | 64,533 | $25.69 | $1.7M | — | View → |
| Mar 18, 2026 | Mar 18 6:17 PM | Farquhar John C.M. | Proposed Sale | 9,725 | $25.00 | $243.1K | — | View → |
| Mar 10, 2026 | Mar 12 11:55 PM | John C.M. FarquharDirector, Chief Executive Officer | Sale | 12,837 | $22.66 | $290.9K | 581,450(D) | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | Jun 18 9:37 PM | William C WeldonDirector | Grant/Award | 16,075 | $32.05 | 16,075(D) | View → |
| Jun 16, 2026 | Jun 18 9:31 PM | Timothy C BarabeDirector | Grant/Award | 16,075 | $32.05 | 16,075(D) | View → |
| Jun 16, 2026 | Jun 18 9:30 PM | Julie A CullivanDirector | Grant/Award | 16,075 | $32.05 | 16,075(D) | View → |
| Jun 16, 2026 | Jun 18 9:28 PM | Jeffrey C LightcapDirector | Grant/Award | 16,075 | $32.05 | 16,075(D) | View → |
| Jun 16, 2026 | Jun 18 9:27 PM | Wayne Joseph RileyDirector | Grant/Award | 16,075 | $32.05 | 16,075(D) | View → |
| Jun 16, 2026 | Jun 18 9:26 PM | Casey M TanseyDirector | Grant/Award | 16,075 | $32.05 | 16,075(D) | View → |
| Jun 15, 2026 | Jun 17 9:39 PM | Campbell RogersChief Medical Officer | Option Exercise | 10,000 | $2.22 | 71,633(D) | View → |
| May 18, 2026 | May 20 9:55 PM | Campbell RogersChief Medical Officer | Option Exercise | 9,219 | $19.00 | 101,410(D) | View → |
| Apr 1, 2026 | Apr 3 10:15 PM | Campbell RogersChief Medical Officer | Option Exercise | 67,017 | $8.33 | 81,633(D) | View → |
| Mar 19, 2026 | Mar 23 10:33 PM | Campbell RogersChief Medical Officer | Option Exercise | 67,017 | $2.22 | 141,510(D) | View → |
| Mar 11, 2026 | Mar 12 11:57 PM | Timothy C BarabeDirector | Option Exercise | 8,667 | $2.22 | 15,412(D) | View → |
| Feb 17, 2026 | Feb 20 12:14 AM | Timothy C BarabeDirector | Option Exercise | 2,497 | $8.33 | 0(D) | View → |
| Feb 12, 2026 | Feb 18 1:07 AM | Campbell RogersChief Medical Officer | Option Exercise | 67,016 | $8.33 | 208,527(D) | View → |
| Feb 6, 2026 | Feb 11 1:55 AM | Marie L. JonesChief Accounting Officer, VP | Grant/Award | 37,795 | $27.74 | 37,795(D) | View → |
| Feb 6, 2026 | Feb 11 1:24 AM | John C.M. FarquharDirector, Chief Executive Officer | Grant/Award | 321,259 | $27.74 | 321,259(D) | View → |
| Feb 6, 2026 | Feb 11 1:21 AM | Campbell RogersChief Medical Officer | Grant/Award | 94,488 | $27.74 | 94,488(D) | View → |
| Feb 6, 2026 | Feb 11 1:18 AM | Vikram VergheseChief Financial Officer | Grant/Award | 119,685 | $27.74 | 119,685(D) | View → |